These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29634384)

  • 1. Inhibition of breast cancer cell growth by the combination of clofarabine and sulforaphane involves epigenetically mediated CDKN2A upregulation.
    Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(5):280-289. PubMed ID: 29634384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane Alone and in Combination with Clofarabine Epigenetically Regulates the Expression of DNA Methylation-Silenced Tumour Suppressor Genes in Human Breast Cancer Cells.
    Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
    J Nutrigenet Nutrigenomics; 2015; 8(2):91-101. PubMed ID: 26372775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
    Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
    Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells.
    Lubecka K; Kaufman-Szymczyk A; Cebula-Obrzut B; Smolewski P; Szemraj J; Fabianowska-Majewska K
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ; Schneider P; Pieters R; Stam RW
    Eur J Cancer; 2015 Sep; 51(14):2008-21. PubMed ID: 26188848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofarabine induces hypomethylation of DNA and expression of Cancer-Testis antigens.
    Zhang Y; Shahriar M; Zhang J; Ahmed SU; Lim SH
    Leuk Res; 2009 Dec; 33(12):1678-83. PubMed ID: 19427036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of clofarabine on transcriptional activity of PTEN, APC, RARB2, ZAP70 genes in K562 cells.
    Majda K; Kaufman-Szymczyk A; Lubecka-Pietruszewska K; Bednarek A; Fabianowska-Majewska K
    Anticancer Res; 2010 Nov; 30(11):4601-6. PubMed ID: 21115912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
    Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
    Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clofarabine in ALL inhibition through DNA methylation regulation.
    Kaufman-Szymczyk A; Lubecka K
    Acta Biochim Pol; 2020 Jan; 67(1):65-72. PubMed ID: 31999420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
    Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clofarabine on apoptosis and DNA synthesis in human epithelial colon cancer cells.
    Wang X; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):414-8. PubMed ID: 20544529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase‑dependent apoptosis.
    Kaufman-Szymczyk A; Majda K; Szuławska-Mroczek A; Fabianowska-Majewska K; Lubecka K
    Mol Med Rep; 2019 Oct; 20(4):3597-3608. PubMed ID: 31485618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of anti-cancer action and pharmacology of clofarabine.
    Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
    Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofarabine acts as radiosensitizer in vitro and in vivo by interfering with DNA damage response.
    Cariveau MJ; Stackhouse M; Cui XL; Tiwari K; Waud W; Secrist JA; Xu B
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):213-20. PubMed ID: 18037589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA Methylation.
    Kaufman-Szymczyk A; Majewski G; Lubecka-Pietruszewska K; Fabianowska-Majewska K
    Int J Mol Sci; 2015 Dec; 16(12):29732-43. PubMed ID: 26703571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
    Royston KJ; Paul B; Nozell S; Rajbhandari R; Tollefsbol TO
    Exp Cell Res; 2018 Jul; 368(1):67-74. PubMed ID: 29689276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism.
    Remmerie M; Dok R; Wang Z; Omella JD; Alen S; Cokelaere C; Lenaerts L; Dreesen E; Nuyts S; Derua R; Janssens V
    Cell Oncol (Dordr); 2024 Oct; 47(5):1811-1829. PubMed ID: 38888850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofarabine.
    Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofarabine: past, present, and future.
    Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
    Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.